Cargando…

LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis

Background: Growing evidence shows that long noncoding RNAs (lncRNAs) play a crucial role in cancer progression. However, whether lncRNA CDKN2BAS is involved in human hepatocellular carcinoma (HCC) metastasis remains unclear. Methods: Human lncRNA microarray analysis was performed to detect differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Junzheng, Huang, Xitian, Wang, Weijun, Xie, Hongcheng, Li, Jianfeng, Hu, Zhenfen, Zheng, Zhijian, Li, Huiyong, Teng, Lingfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286843/
https://www.ncbi.nlm.nih.gov/pubmed/30510148
http://dx.doi.org/10.18632/aging.101645
_version_ 1783379535339716608
author Chen, Junzheng
Huang, Xitian
Wang, Weijun
Xie, Hongcheng
Li, Jianfeng
Hu, Zhenfen
Zheng, Zhijian
Li, Huiyong
Teng, Lingfang
author_facet Chen, Junzheng
Huang, Xitian
Wang, Weijun
Xie, Hongcheng
Li, Jianfeng
Hu, Zhenfen
Zheng, Zhijian
Li, Huiyong
Teng, Lingfang
author_sort Chen, Junzheng
collection PubMed
description Background: Growing evidence shows that long noncoding RNAs (lncRNAs) play a crucial role in cancer progression. However, whether lncRNA CDKN2BAS is involved in human hepatocellular carcinoma (HCC) metastasis remains unclear. Methods: Human lncRNA microarray analysis was performed to detect differential expression levels of lncRNAs in metastatic HCC tissues. Effects of CDKN2BAS on cell proliferation, migration, and apoptosis were determined by MTT assay, colony formation assay, migration assay, scratch assay, and flow cytometry. The xenograft experiment was used to confirm the effect of CDKN2BAS on HCC in vivo. qRT-PCR and Western blot were performed to determine the expression levels of mRNAs and proteins. Luciferase reporter assay was used to identify the specific target relationships. Results: CDKN2BAS was remarkably up-regulated in metastatic HCC tissues compared with the adjacent non-tumor tissues. CDKN2BAS promotes HCC cell growth and migration in vitro and in vivo. Additionally, CDKN2BAS upregulated the expression of Rho GTPase activating protein 18 (ARHGAP18) by sponging microRNA-153-5p (miR-153-5p), and thus promoted HCC cell migration. Besides, CDKN2BAS downregulated the expression of Krüppel-like factor 13 (KLF13) and activated MEK-ERK1/2 signaling, thus reducing apoptosis in HCC cells. Conclusions: Our study revealed that lncRNA CDKN2BAS promotes HCC metastasis by regulating the miR-153-5p/ARHGAP18 signaling.
format Online
Article
Text
id pubmed-6286843
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-62868432018-12-17 LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis Chen, Junzheng Huang, Xitian Wang, Weijun Xie, Hongcheng Li, Jianfeng Hu, Zhenfen Zheng, Zhijian Li, Huiyong Teng, Lingfang Aging (Albany NY) Research Paper Background: Growing evidence shows that long noncoding RNAs (lncRNAs) play a crucial role in cancer progression. However, whether lncRNA CDKN2BAS is involved in human hepatocellular carcinoma (HCC) metastasis remains unclear. Methods: Human lncRNA microarray analysis was performed to detect differential expression levels of lncRNAs in metastatic HCC tissues. Effects of CDKN2BAS on cell proliferation, migration, and apoptosis were determined by MTT assay, colony formation assay, migration assay, scratch assay, and flow cytometry. The xenograft experiment was used to confirm the effect of CDKN2BAS on HCC in vivo. qRT-PCR and Western blot were performed to determine the expression levels of mRNAs and proteins. Luciferase reporter assay was used to identify the specific target relationships. Results: CDKN2BAS was remarkably up-regulated in metastatic HCC tissues compared with the adjacent non-tumor tissues. CDKN2BAS promotes HCC cell growth and migration in vitro and in vivo. Additionally, CDKN2BAS upregulated the expression of Rho GTPase activating protein 18 (ARHGAP18) by sponging microRNA-153-5p (miR-153-5p), and thus promoted HCC cell migration. Besides, CDKN2BAS downregulated the expression of Krüppel-like factor 13 (KLF13) and activated MEK-ERK1/2 signaling, thus reducing apoptosis in HCC cells. Conclusions: Our study revealed that lncRNA CDKN2BAS promotes HCC metastasis by regulating the miR-153-5p/ARHGAP18 signaling. Impact Journals 2018-11-29 /pmc/articles/PMC6286843/ /pubmed/30510148 http://dx.doi.org/10.18632/aging.101645 Text en Copyright © 2018 Chen et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY) 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Chen, Junzheng
Huang, Xitian
Wang, Weijun
Xie, Hongcheng
Li, Jianfeng
Hu, Zhenfen
Zheng, Zhijian
Li, Huiyong
Teng, Lingfang
LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis
title LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis
title_full LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis
title_fullStr LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis
title_full_unstemmed LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis
title_short LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis
title_sort lncrna cdkn2bas predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the mir-153-5p/arhgap18 signaling axis
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286843/
https://www.ncbi.nlm.nih.gov/pubmed/30510148
http://dx.doi.org/10.18632/aging.101645
work_keys_str_mv AT chenjunzheng lncrnacdkn2baspredictspoorprognosisinpatientswithhepatocellularcarcinomaandpromotesmetastasisviathemir1535parhgap18signalingaxis
AT huangxitian lncrnacdkn2baspredictspoorprognosisinpatientswithhepatocellularcarcinomaandpromotesmetastasisviathemir1535parhgap18signalingaxis
AT wangweijun lncrnacdkn2baspredictspoorprognosisinpatientswithhepatocellularcarcinomaandpromotesmetastasisviathemir1535parhgap18signalingaxis
AT xiehongcheng lncrnacdkn2baspredictspoorprognosisinpatientswithhepatocellularcarcinomaandpromotesmetastasisviathemir1535parhgap18signalingaxis
AT lijianfeng lncrnacdkn2baspredictspoorprognosisinpatientswithhepatocellularcarcinomaandpromotesmetastasisviathemir1535parhgap18signalingaxis
AT huzhenfen lncrnacdkn2baspredictspoorprognosisinpatientswithhepatocellularcarcinomaandpromotesmetastasisviathemir1535parhgap18signalingaxis
AT zhengzhijian lncrnacdkn2baspredictspoorprognosisinpatientswithhepatocellularcarcinomaandpromotesmetastasisviathemir1535parhgap18signalingaxis
AT lihuiyong lncrnacdkn2baspredictspoorprognosisinpatientswithhepatocellularcarcinomaandpromotesmetastasisviathemir1535parhgap18signalingaxis
AT tenglingfang lncrnacdkn2baspredictspoorprognosisinpatientswithhepatocellularcarcinomaandpromotesmetastasisviathemir1535parhgap18signalingaxis